Masimo Corporation (NASDAQ:MASI) Q3 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, good afternoon, and welcome to Masimo's Third Quarter 2024 Earnings Conference Call. The company's press release is available at www.masimo.com.
Masimo Corp (MASI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Politan Capital Quentin Koffey | 4,714,746 | $628,617,084 | 35.49% | |
| 2. | Farallon Capital Thomas Steyer | 1,258,563 | $167,804,205 | +13% | 0.82% |
| 3. | Holocene Advisors Brandon Haley | 875,159 | $116,684,949 | -16% | 0.47% |
| 4. | Alyeska Investment Group Anand Parekh | 745,127 | $99,347,783 | +73% | 0.5% |
| 5. | GLG Partners Noam Gottesman | 399,945 | $53,324,667 | +38% | 0.13% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $158.19 | 500 | Officer, Director | 366,055 | 2023-05-25 | Filing | |
| $157.53 | 2,265 | Officer, Director | 365,555 | 2023-05-25 | Filing | |
| $156.79 | 3,600 | Officer, Director | 363,290 | 2023-05-25 | Filing | |
| $146.23 | 1,541 | Officer, Director | 46,818 | 2022-12-15 | Filing | |
| $145.22 | 2,039 | Officer, Director | 45,277 | 2022-12-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $136.17 | 40,000 | Director | 7,406 | 2024-04-26 | Filing | |
| $273.18 | 2 | Officer, Director | 10,366 | 2022-01-01 | Filing | |
| $214.80 | 600 | Director | 1,751 | 2022-01-24 | Filing | |
| $228.70 | 600 | Director | 2,351 | 2022-01-18 | Filing | |
| $250.01 | 600 | Director | 2,951 | 2022-01-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,927,572 | $811,980,724 | 0.06% | |
| 2. | 5,659,131 | $663,306,745 | 0.01% | |
| 3. | 4,781,343 | $560,421,213 | 0.01% | |
| 4. | 2,269,189 | $265,971,643 | 0.06% | |
| 5. | 1,607,310 | $188,392,804 | 0.06% |
News See All
8 Most Promising Medical Stocks According to Hedge Funds
The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, and treatment.
Piper Sandler's Top Technical Stock Picks: 20 Best Stocks
The start of October has seen another wild swing for markets. September's second half saw Wall Street rejoice as the Federal Reserve delivered its highly anticipated interest rate cut.
Shake-Up Alert: 40 Companies Facing Activist Pressure
The equity market has been on a roll, rallying by 10% in the first half of 2024, adding to the 24% gain registered in 2024.
Masimo Corporation (NASDAQ:MASI) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to Masimo's Second Quarter 2024 Earnings Conference call. The company's press release is available at www.masimo.com.
What Makes Masimo Corporation (MASI) a “Special Situation Investment”?
Baron Funds, an investment management company, released its “Baron Discovery Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
Masimo Corporation (NASDAQ:MASI) Q1 2024 Earnings Call Transcript
Masimo Corporation misses on earnings expectations. Reported EPS is $0.3487 EPS, expectations were $0.71.
Masimo Corporation (NASDAQ:MASI) Q4 2023 Earnings Call Transcript
Masimo Corporation beats earnings expectations. Reported EPS is $1.25, expectations were $0.95.
25 Most Valuable Medical Device Companies in the US
In this article, we will be taking a look at the 25 most valuable medical device companies in the US.
Masimo Corporation (MASI) Stock Rallied 33.7% in Q4
Ensemble Capital Management, an investment management company, released its fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
